The present invention is related generally to repairing or modifying damaged tissue within a body using a scanning beam unit.
The human body is complex and is often difficult for clinicians to examine internally to diagnose and treat a patient's illness. Cameras play an important part in modern medicine as a tool to aide clinicians in looking within a patient's body. Usually medical cameras are part of larger medical device, such as endoscopes, thermo-vision cameras, or laparoscopes. The cameras are usually digital, fiber optic, or pixelated sensor arrays. The cameras made with a pixelated sensor array may contain a single charge coupled assembly (CCD) or complimentary metal oxide semiconductor (CMOS) chip, or they may have multiple chips. The number of chips affects the size and resolution of the camera, and as a result limits where the camera can be used within the patient's body. There are therapeutic applications where smaller cameras or assemblies would be advantageous.
Recently, an assembly that can reach more remote areas within the body has been developed. This assembly is disclosed in United States Published Patent Application 2005/0020926. This assembly can be adapted to treat as well as to produce images of diseased or damaged tissue.
The present invention provides a method for repairing or modifying an area of a patient's anatomy that comprises directing at least a portion of a scanning beam assembly to an area of a patient's anatomy, applying a radiation-responsive agent to portion of the anatomy, and exposing the radiation-responsive agent to radiation directed onto the agent by the reflector to cause the agent to therapeutically interact with the site. The scanning beam assembly including a radiation source capable of emitting radiation, a reflector that receives the radiation from the radiation source to direct the radiation onto the anatomy, wherein the reflector oscillates in at least two directions to create a scan of the anatomy, a detector to detect radiation returned from the anatomy, and a controller to convert the detected radiation into a displayable anatomy image.
In one embodiment, the present invention provides a method for repairing an area of a patient's anatomy that comprises directing at least a portion of a scanning beam assembly to an area of a patient's anatomy, displaying an image of the anatomy, identifying a portion of the anatomy for the placement of a radiation-responsive agent, applying the radiation-responsive agent to the identified portion of the anatomy, and exposing the agent to radiation directed onto the agent to cause the agent to therapeutically interact with the anatomy. The scanning beam assembly including a radiation source capable of emitting radiation, a reflector that receives the radiation from the radiation source to direct the radiation onto the anatomy, wherein the reflector oscillates in at least two directions to create a scan of the anatomy, a detector to detect radiation returned from the area of the anatomy, and a controller to covert the detected radiation into a displayable anatomy image.
In another embodiment, the present invention provides a balloon catheter that comprises an expandable balloon, a catheter body having a plurality of lumens, wherein at least one lumen opens into the interior of the expandable balloon, and at least a portion of a scanning beam assembly. The scanning beam assembly including a radiation source capable of emitting radiation, a reflector that receives the radiation from the radiation source to direct the radiation onto the a patient's anatomy, wherein the reflector oscillates in at least two directions to create a scan of the anatomy, a detector to detect radiation returned from the anatomy, and a controller to covert the detected radiation into a displayable anatomy image.
In another embodiment, the present invention provides a method for repairing or modifying an area of a patient's anatomy that comprises directing at least a portion of a scanning beam assembly to an area of a patient's anatomy, displaying an image of the anatomy, identifying a portion of the anatomy where the radiation is to make a channel into the anatomy, and emitting the radiation to make the channel. The scanning beam assembly including a radiation source capable of emitting radiation, a reflector that receives the radiation from the radiation source to direct the radiation onto the a patient's anatomy, wherein the reflector oscillates in at least two directions to create a scan of the anatomy, a detector to detect radiation returned from the anatomy, and a controller to convert the detected radiation into a displayable anatomy image.
Before explaining the several embodiments of the present invention in detail, it should be noted that each embodiment is not limited in its application or use to the details of construction and arrangement of parts and steps illustrated in the accompanying drawings and description. The illustrative embodiments of the invention may be implemented or incorporated in other embodiments, variations and modifications, and may be practiced or carried out in various ways. Furthermore, unless otherwise indicated, the terms and expressions employed herein have been chosen for the purpose of describing the illustrative embodiments of the present invention for the convenience of the reader and are not for the purpose of limiting the invention. It is further understood that any one or more of the following-described embodiments, examples, etc. can be combined with any one or more of the other following-described embodiments, examples, etc.
Referring to
The wavelength of radiation, for example, may be selected for imaging, therapy, or aiming. As used herein, an “imaging beam” refers to radiation selected for use in creating an image of a surface or region, a “therapeutic beam” refers to radiation selected to provide treatment of a condition such as diseased or damaged tissue, and an “aiming beam” refers to radiation selected to accentuate a portion of the FOV. The uses and application of such beams is disclosed in commonly assigned U.S. patent application Ser. No. 11/716,806 MEDICAL DEVICE INCLUDING SCANNED BEAM UNIT FOR IMAGING, THERAPY, AND/OR DIAGNOSIS as well as the operation of treatment mapping or selecting a treatment path. This reference is herein incorporated by reference in its entirety. In this example, sources 11, 12 and 13 emit red, green and blue radiation; source 14 emits an aiming beam at a wavelength selected to yield a distinct contrast to the typical target material; and source 15 emits a therapeutic beam at a wavelength that is highly absorbed and moreover can be efficiently generated at high power to treat diseased or damaged tissue. In some embodiments, the aiming beam may be provided by source separate from the therapeutic beam source 15. As an alternative, an aiming beam may be provided by source 15 as a reduced power therapeutic beam. In some embodiments, the aiming beam could be a virtual beam (i.e., a region in which one or more of the imaging sources is caused to increase (or decrease) significantly to create a bright (or dark) region in the displayed image.
In some embodiments, a source (not shown) provides a diagnostic beam. A “diagnostic beam” as used herein refers to radiation selected for analysis or detection of a disease or other medical condition including, for example, to visualize the presence of (or to activate) a diagnostic marker. The diagnostic marker could be naturally occurring (e.g., auto or self fluorescence) or introduced as part of the diagnostic procedure (e.g., fluorescent dyes).
Use of an aiming beam may be preferred in some circumstances. As will be seen later, while the treatment beam may follow the same path as the imaging beam, it is not constrained to follow the same timing. An aiming beam, managed in the same way as the therapeutic beam though at lower power and in a visible wavelength, may help ensure that the treatment is applied where the user intends. Furthermore, it may be a requirement of certain industry or regulatory standards such as AAMI or IEC that where higher power lasers are employed, an aiming beam be provided.
It should be noted that while five sources are illustrated, there may be more or fewer emitters depending, for example, on the end use. In some embodiments, sources may be combined or capable of providing various types of energy. In some cases, filters may be used to filter the radiation. In some embodiments, sources 11, 12 and 13 comprise three lasers; a red diode laser, a green diode-pumped solid state (DPSS) laser, and a blue DPSS laser at approximately 635 nm, 532 nm, and 473 nm, respectively. While laser diodes may be directly modulated, DPSS lasers generally require external modulation such as an acousto-optic modulator (AOM) for instance. In the case where an external modulator is used, it is considered part of the radiation source assembly and not shown separately.
Some embodiments use a micro-electromechanical (MEMS) scanner reflector to direct the imaging, aiming and therapeutic beams onto the surface. MEMS scanner reflectors are described in, for example, U.S. Pat. No. 6,140,979, entitled SCANNED DISPLAY WITH PINCH, TIMING, AND DISTORTION CORRECTION; U.S. Pat. No. 6,245,590, entitled FREQUENCY TUNABLE RESONANT SCANNER AND METHOD OF MAKING; U.S. Pat. No. 6,285,489, entitled FREQUENCY TUNABLE RESONANT SCANNER WITH AUXILIARY ARMS; U.S. Pat. No. 6,331,909, entitled FREQUENCY TUNABLE RESONANT SCANNER; U.S. Pat. No. 6,362,912, entitled SCANNED IMAGING APPARATUS WITH SWITCHED FEEDS; U.S. Pat. No. 6,384,406, entitled ACTIVE TUNING OF A TORSIONAL RESONANT STRUCTURE; U.S. Pat. No. 6,433,907, entitled SCANNED DISPLAY WITH PLURALITY OF SCANNING ASSEMBLIES; U.S. Pat. No. 6,512,622, entitled ACTIVE TUNING OF A TORSIONAL RESONANT STRUCTURE; U.S. Pat. No. 6,515,278, entitled FREQUENCY TUNABLE RESONANT SCANNER AND METHOD OF MAKING; U.S. Pat. No. 6,515,781, entitled SCANNED IMAGING APPARATUS WITH SWITCHED FEEDS; U.S. Pat. No. 6,525,310, entitled FREQUENCY TUNABLE RESONANT SCANNER; and U.S. patent application Ser. No. 10/873,540, entitled SCANNING ENDOSCOPE; all of which are hereby incorporated by reference in their entirety as if fully set forth herein.
In some embodiments, X represents an input to the detectors 37 capable of modifying the transfer function from radiation to electric signals. Exemplary modifications may include adjustment of gain or offset or both. Y may represent an input to the wavelength separator 35 capable of modifying the transfer function therethrough. The modifying elements X and Y may be disposed to operate on the input to the respective detectors 37 and wavelength separator 35, acting on all or a subset of wavelengths received, at the outputs of the respective detectors 37 and wavelength separator 35 or at both inputs and outputs.
In some embodiments, motion sensing is incorporated within the system via target feature motion detection, element T. For example, element P may include a number of sensors attached or connected to the scanner assembly 2. The sensors may sense location, orientation or both. The sensors may be, for example, accelerometers, magnetometers, rate gyros, electromagnetic position sensors, etc. Element Q represents the location and orientation signals generated by the sensors and element R represents a mathematic operation capable of converting the signals Q into a stationary reference frame. Element S represents output of element R which is used to modify the relationship of a displayed image to the scanned data 49 to compensate for sensed movement.
Element R operates on the scanned data 49 to detect the relative movement and provides signals U indicating magnitude and direction of the movement. This image tracking functionality may provide reliable treatment of the body which might be moving due to, for example, respiration, circulation or other biological activity.
Electrical wires 52 convey drive signals for the reflector 27 and other signals (position feedback, temperature, etc.) to and from the scanner driver 45 (
In another embodiment, as shown in
Referring now to
In one embodiment, a user defines a treatment zone, border, or path by identifying the places within the image of the FOV where treatment is to be administered. The user may also select the parameters for the treatment such as the treatment beam wavelength, the power of the beam, and the duration of the exposure. The power of the beam may be modulated by a modulator to achieve the power selected by the user, as taught in commonly assigned U.S. patent application Ser. No. 11/716,911, titled POWER MODULATION OF A SCANNING BEAM FOR IMAGING, THERAPY, AND/OR DIAGNOSIS
While the discussion below refers to radiation-responsive agents, such as adhesives or medical drugs, those skilled in the art will recognize that the techniques described herein can be used to activate any photo or radiation responsive agent useful in medical applications. Referring now to
The step of applying a radiation-responsive agent to the site 91 may be performed by any medical procedure or assembly that can successfully deliver the radiation-responsive agent to the site to be treated using the scanning beam assembly. In one embodiment, an applicator (i.e., a tube, sprayer, or the like) may be threaded down the working channel of endoscope or a laparoscope. In another embodiment, the applicator may be inserted through a trocar to apply the radiation-responsive agent. In yet another embodiment the radiation-responsive agent may be applied through a working channel or lumen within a catheter, balloon catheter, or the like. In one embodiment, the scanning beam assembly 1 is capable of curing all or selectively curing only a pre-determined portion of the agent the clinician indicates needs to be cured. The tool, assembly, or process chosen to apply the radiation-responsive agent will vary with the location within the body that needs to be reached for treatment, the radiation-responsive agent chosen, the form of the chosen radiation-responsive agent, and the size of the site to be treated.
The radiation-responsive agent may be any molecule, composition, or mixture capable of forming a biological, biocompatible, or biodegradable agent that does not cause adverse reaction in the tissue undergoing treatment. In another embodiment, the radiation responsive agent include a biocompatible coating that allows them to be safely placed within the patient's anatomy. The radiation-responsive agent may be a radiation curable molecule, compound, or composition. The radiation used to cure the radiation-responsive agent may be ultraviolet radiation, infrared, near infrared, or any other electromagnetic radiation. In one embodiment the radiation-responsive agent may be a medical adhesive that is capable of cross-linking when exposed to electromagnetic radiation. In another embodiment, the agent may be a medical drug that is activated by radiation. In another embodiment, the radiation-responsive agent is a shape-memory alloy. In another embodiment the radiation responsive agent may be a material that acts to promotes tissue welding or sealing, in the same manner as solder flux does with two pieces of metal.
The medical adhesive may be a gelatin or esterified gelatin as taught in U.S. Pat. No. 7,033,348, un-polymerized and polymerized type I and/or type III collagen compositions as taught in United States Published Application US2003/0032143, a composition of poly(L-lactic-co-glycolic acid), glycolic co-polymer, and bovine serum albumin as taught in United States Published Application US2004/0236371, a moiety containing a photosensitizing species and a protein or peptide as taught in U.S. Pat. No. 5,552,452, or any combination or mixture thereof. In another embodiment, to ensure that the medical adhesive cures when exposed to the radiation from the scanning beam assembly other molecules, compounds, or mixtures may be added to the agent.
In another embodiment the medical adhesive may be a proteinaceous biomolecule or a biological, biodegradable polypeptides as taught in U.S. Pat. Nos. 6,583,117 and 7,078,378. A proteinaceous biomolecule agent is a protein, which may be any protein or mixture of proteins. Examples of suitable proteins includes but is not limited to albumins, collagen, fibrinogen, tropoelastin, and elastin. Suitable proteins are typically those which can be cross-linked to form a matrix and which can be absorbed by the body. A biological, biodegradable polypeptides includes synthetic polypeptides incorporate light-absorbing material, such as a dye, into the agent, to improve energy absorption and cure. Examples of a suitable dyes include but are not limited to indocyanine green, methylene blue and fluorescein isothiocyanate. It will be understood that the light-absorbing material is chosen to be appropriate to the energy source that is used in forming tissue repairs involving the use of the medical adhesive.
The radiation-responsive agent may be a paste, gel, liquid, solid, pliable solid, powder, ribbon, mesh, film, metal or polymer scaffold or graft material. In one embodiment, a pliable radiation-responsive agent may be embedded into the spaces within a mesh or it may be applied as a covering to all or part of the mesh, stiffener or graft material. The pliable radiation-responsive agent may be shaped into various forms, such as tubular forms tapered or of uniform cross section. The tubular forms may be round or of ovoid profile, square crenulated, or any other geometric form. The radiation-responsive agent may be prepared in other shapes as required for the particular application to the treatment site including strips, patches, solid rods and hollow cubes with or without a flanged end. In another embodiment, the radiation-responsive agent composition may include medicinal drugs that aide in healing or treatment of the treatment site. The radiation-responsive agent referenced throughout the paragraphs below may be applied in any of the forms and may be any type of agent described above or combinations thereof.
The step of exposing the radiation-responsive agent with radiation emitted from the scanning beam assembly 93 may be carried out by selecting a desired wavelength, or plurality of wavelengths of radiation to be directed at the site where the radiation-responsive agent is applied. The scanning beam assembly 1 may have multiple lasers, light emitting diodes, thermal sources, arc sources, or fluorescent sources as source assembly 4. Any of sources 11-15 may also function as a therapeutic beam to cure the radiation-responsive agent. If sources 11-15 are not effective to cure the agent, then another source emitting the necessary cure radiation may be added to the assembly or substituted for one of these sources. As used herein, therapeutically interact includes, but is not limited thereto, when the agent bonds or adheres to the anatomy where the agent was applied, the agent cures or is cross-linked into a more rigid structure by the radiation, the agent expands to fill a void, the agent kills diseased tissue, the agent applies a medicine to promote healing, the agent forms a graft to the anatomy, the agent forms a stent within the anatomy, or the like.
The scanning beam assembly 1 may be connected to or configured with a display system that works in conjunction with a computer to plan and identify the site to be treated. A clinician may view the displayed image and then confirm and/or select a treatment path using the display, computer keyboard, or mouse. The treatment path corresponds to the tissue in need of treatment found within the site of visualization. For more details on selecting the treatment path see commonly assigned U.S. patent application Ser. No. 11/716,806 MEDICAL DEVICE INCLUDING SCANNED BEAM UNIT FOR IMAGING, THERAPY, AND/OR DIAGNOSIS, incorporated by reference above.
In another embodiment, it is possible that the computer can pre-determine the type of treatment based on optical information collected from the scene. For example, a dye may be used to stain particular tissue, then the computer may analyze the stains and suggest treatment options. In another embodiment, the computer can be programmed to automatically recognize certain tissue types, for example cancerous tissue, either via autofluorescence, impregnated dye fluorescence, or color-based analysis, and automatically select the zones in the scene that correlate to the targeted tissue. The computer would indicate to the physician the identified targets for confirmation. Once the clinician is satisfied with the treatment, they can move the scope to the next area to be treated.
The therapeutic beam or laser then cures the radiation-responsive agent along the treatment path, which enables the clinician to selectively treat only a portion of the radiation-responsive agent. A bioabsorbable radiation-responsive agent may be useful when the agent is cured selectively, in that any uncured agent may be absorbed by the body and not require the clinician to remove the excess. In one embodiment the laser treatment path may be followed continuously without visualization. In another embodiment, the laser treatment path may be interspersed with the visualization to allow the clinician to monitor the treatment progress. In yet another embodiment the scanning beam assembly 1 may be capable of treating and visualizing simultaneously. Additionally, the clinician may select whether the treatment is itself continuous or pulsated.
The method as described above for repairing a site within a body may be useful in closing gastric incisions, bonding two tissues together, soft tissue attachment, reconnecting tubular vessels, placing stents within body passageways, killing cancer cells or tumors, treating diseased tissue, or placing grafts within the body (such as intraluminal grafts). The reflector 27 of the scanning beam assembly 1 may vary in size, but are capable of being made smaller than the typical cameras. Reflector 27 may be held within a housing that is as small as about 3 to about 4 millimeters by about 4 millimeters to about 10 millimeters. This small size enables the scanning beam assembly to be carried on or in a catheter and threadedly delivered to visualize areas inside the lumen of the body or other hard to reach places, including but not limited to large veins and arteries. In some embodiments, scanner assembly 2, which includes reflector 27, may be included within the central void 61 of housing 62 shown in
In another embodiment, as illustrated in
In one embodiment, the balloon may be similar to the balloon catheter taught in U.S. Pat. No. 6,056,721, as shown in
The distal end 326 preferably terminates at a distal tip 327. A hub 332 having a plurality of extension tubes 334 may be coupled to the proximal end 324 of the catheter body 320. The hub 332 may be adapted to be a hand piece when the balloon catheter 300 is used with the scanning beam assembly 1. Each of the extension tubes 334 may be connected with a respective one of the plurality of lumens 328a-328d such that each lumen 328a-328d is fluidly coupled or otherwise in open communication with an extension tube 334. A connecter 336, such as a luer lock, may be provided at a proximal end 338 of each extension tube 334. The detector may be a multi-mode optical fiber or an optical to electrical converter (i.e. a photodiode) that transmits the reflected signal.
In one embodiment, the balloon catheter 300 may have a first balloon 346. The first balloon 346 may be a round or semi-round balloon. The balloon 346 is preferably made from a flexible and bio-compatible material. These materials may include a rubber such as a medical grade latex, a silicone, polyurethane, polyethylene, polyethylene terephthalate, polyvinyl chloride, nylon and ionomers such as Surlyn, manufactured by the Polymer Products Division of the Du Pont Company. The first balloon 346 may act as a seal around a passageway or act as an anchor within the passageway.
In another embodiment, the balloon catheter 300 may have a second inflatable and deflatable angioplasty balloon 350. This second balloon 350 may have a central portion 354. The second balloon 350 may be made of any of the materials mentioned above, or any other material capable of being inflated and deflated by a fluid or gas. In one embodiment, the material may be any material capable of allowing radiation to pass through the material to activate a radiation-responsive agent contained on the outside of the second balloon 350. In one embodiment both the first and second balloon, 346 and 350 respectively, may be present as shown in
In one embodiment, balloon catheter 300 contains connecting cable 304 and a scanning module 302. Scanning module 302 is a portion of scanning beam assembly 1, which in some embodiments includes scanner assembly 2 within the central void 61 of housing 62 including collectors 3 (shown in
Scanning beam assembly 1 may include a display system on which a clinician may see the anatomy and determine how to treat a site within that area. To see an image when scanning module 302 is within the second balloon 350, second balloon 350 may be made of a material that allows the imaging wavelengths from the source assembly 4 to pass through the balloon material and likewise the returned radiation from the field of view pass back through the balloon material. In one embodiment, the scanning module 302 may be moved or directed while inside the second balloon 350 using the a hand piece or steering control that may be included as part of scanning beam assembly 1.
In another embodiment, scanning module 302 and connecting cable 304 may be external to the balloon catheter 300 in any location that will allow the radiation emitted from the scanning module 302 to reach the radiation-responsive agent to cure it or cause it to therapeutically interact with the tissue site. In one embodiment, the scanning module 302 may be near the distal tip 327 directing the scanning beam back at the second balloon 350, or in another embodiment the scanning module 302 may be between the first balloon 346 and the second balloon 350 directing the emitted radiation toward the second balloon 350. In another embodiment, mirrors may be used in conjunction with the scanning module 302 to direct the radiation around the second balloon.
The step of dispensing a radiation-responsive agent onto the balloon catheter 320 may be carried out using an infusion port 340 in the catheter body 320 as shown in
In one embodiment, the infusion port 340 may be used to disperse a radiation-responsive agent 344 into the flow passageway 318 to cover the external surface of the second balloon 350. The infusion port 340 may be fluidly coupled to an infusion lumen 328a, as shown in
In one embodiment, the infusion port 340 may be a single oval, circular, or any other shaped port. In another embodiment, the infusion port 340 may be a plurality of openings or ports spaced uniformly or non-uniformly circumferentially around the catheter body 320. The spacing and placement of the plurality of infusion ports 340 may be such that the radiation-responsive agent when pumped through a lumen 328a will efficiently and effectively flow to cover the central portion 354 of the second balloon 350. The infusion lumen 328a may be connected in fluid communication with a working channel on a hand piece or a hose included as part of the scanning beam assembly 1. The working channel and/or hose may be used to force or pump the radiation-responsive agent toward the distal end 327 of the balloon catheter 300 such that the radiation-responsive agent 344 is pushed through the infusion port 340. The infusion lumen 328a should comprise a sufficiently large cross sectional area along the catheter body 320 to allow for passage of a large volume of the radiation-responsive agent. The infusion lumen 328a may also be configured with a circular, oval, square, trapezoidal, rhomboidal, or any other shaped cross section.
A second lumen 328b of the plurality of lumens 328a-328d extends from the proximal end 324 of the catheter body 320 and is fluidly connected to an opening or openings in the outer wall 330 of the catheter body 320 within the first balloon 346. The third lumen 328c of the plurality of lumens 328a-328d extends from the proximal end 324 of the catheter body 320 and is fluidly connected to an opening or openings in the outer wall 330 of the catheter body 320 within the second balloon 350. The fourth lumen 328d, may be configured for movably supporting a connecting cable 304 and scanning module 302.
In one embodiment, the radiation-responsive agent 344 may be passed through infusion lumen 328a, exiting from infusion port 340 disposed between the first balloon 346 and the second balloon 350. The radiation-responsive agent 344 may be infused at a pressure greater than the pressure within the angioplasty balloon 350 but less than the pressure within the first balloon 346. This allows the radiation-responsive agent 344 to exit the infusion port 340 into the sealed space between the first balloon 346 and the second balloon 350. The radiation-responsive agent 344 may then seep around the inflated central portion 354 of the second balloon 350. In one embodiment, the second balloon 350 may be completely deflated when the radiation-responsive agent 344 is applied. In another embodiment, the second balloon 350 may be partially inflated when the radiation-responsive agent 344 is applied.
In another embodiment, as shown in
In one embodiment, as shown in
The balloon catheters of the embodiment shown in FIGS. 17,18 may further include cover 366 illustrated in
The second balloon 350 is then expanded to apply the radiation-responsive agent 344 to the site to be treated within body passageway 312. In this configuration, the radiation-responsive agent 344 is uniformly applied at a uniform pressure to the interior surface of the body passageway 312. Some of the radiation-responsive agent 344 may flows into any cracks, depressions, or tears within the body passageway 312 or obstructing material 316. The radiation-responsive agent 344 therapeutically interacts with the body passageway to bond to the tissue to stay in place, to treat diseased tissue, or to cure into a thin walled tubular member, known as a stent 368. Stent 368 is shown in
Then the radiation-responsive agent 344 is exposed to radiation emitted from the scan beam assembly's scanning module 302 to cure or cross-link the agent, as explained above. In one embodiment, the radiation-responsive agent 344 may be cured selectively such that the resulting stent 368 is a scaffold of cured agent similar to a metal self-expanding stent as shown in U.S. Pat. No. 5,545,211. In another embodiment the radiation-responsive agent 344 may be gradually cured or “grown” to a custom length by scanning the agent repeatedly using the method above while gradually moving the catheter along the anatomy. In one embodiment, the radiation-responsive agent of stent 368 is selectively cured to form a stent with slots throughout. The slots may be substantially parallel to a long axis of stent 368, perpendicular to the long axis, or a combination thereof.
In one embodiment, the radiation-responsive agent 344 is a bioabsorbable composition such that the resulting agent cured stent is a temporary stent that will be absorbed slowly by the body, which eliminates a second procedure to remove the stent. In another embodiment, the radiation-responsive agent 344 is a composition that is not bioabsorbable such that the resulting agent cured stent is a more permanent stent.
Bonding Separated Tissues
FIGS. 21,22 illustrate different embodiments for bonding separated tissues together by the application of a gel, film, mesh, paste, powder, ribbon, or solid radiation-responsive agent 430 and the curing due to exposure to radiation from scanning beam assembly 1. In one embodiment, scanning module 402, which is connected to scanning beam assembly 1 by connecting cable 404 is inserted within the area of the body to be exposed to radiation or is aligned with the area of the body to be exposed. The radiation-responsive agent 430 may be any of the agents listed above, or combinations thereof. In one embodiment, the radiation-responsive agent may include a catalyst to aid in absorbing the radiation and/or a glue to hold the agent into place prior to curing. First and second tissues 410 and 420 to be joined together are brought within close proximity with one another. The separation of the first and second tissues 410 and 420 may be a surgical incision, an accidental cut, a tear, or a separation of tissue interior to or exterior to the body.
In one embodiment, as shown in
In another embodiment, as shown in
In one embodiment, the laser light 440 emitted from the scanning module 402 is scanned across the tissue interface 450 from the first tissue 410 to the second tissue 420 then back to the first tissue 410 repeatedly along the length of the tissue interface 450. Scanning module 402 is a portion of scanning beam assembly 1, which in some embodiments includes scanner assembly 2 within the central void 61 of housing 62 including collectors 3 (shown in
In one embodiment, the laser light 440 may be a high power infrared laser. In another embodiment, the clinician may set a scanning treatment plan using a touch-screen input or computer as part of the scanning beam assembly 1. The scanning treatment plan may encompass any pattern of scanning, including those described above to cure all or a selected portion of the agent. The clinician may select the laser light 440 to be emitted as a continuous stream or as a pulse stream.
Shape Memory Alloy Stents
Stent 510 may be an angioplasty stent for use in the coronary artery, femoral artery, renal artery, or carotid artery, or a renal stent for use in the ureter, or a biliary tree stent for use in the biliary duct, or a prostatic stent for use in the urethra, or a transjugular intrahepatic portosystemic shunt for use in the hepatic portal veins, or any other stent for treating a tubular passageway within the body.
In
In
Stent 510 may be constructed as taught in U.S. Pat. No. 5,649,952, U.S. Pat. No. 5,545,211, U.S. Pat. No. 6,976,994, U.S. Pat. No. 6,974,472, or U.S. Pat. No. 7,035,777. In one embodiment the stent may be made of shape memory alloy, which may be manufactured by the methods taught in U.S. Pat. No. 7,112,302.
As used herein, the term “shape memory alloy” or SMA is broadly defined as a metal-based alloy having a reversible solid-state transformation typically known as a martensitic transformation. Such materials typically exhibit the shape-memory effect and superelasticity distinct from conventional metals and alloys. These materials may be ferrous or non-ferrous martensites. Such materials include, but are not limited to, iron-based alloys, copper-based alloys, and nickel-titanium alloys. Ferrous systems include, but are not limited, iron and at least one of manganese, silicon, chromium and nickel, such as iron-manganese-silicon alloys and iron-chromium-nickel alloys. Copper-based systems are typically derived from copper-zinc, copper-aluminum, and copper-tin systems. Copper systems include, but are not limited to, copper and at least one of zinc, aluminum and nickel, such as copper-zinc-aluminum alloys, copper-nickel-aluminum alloys, and copper-beryllium-aluminum alloys. Nickel based systems include, but are not limited to nickel and at least one of titanium, copper, niobium, palladium, zirconium, and hafnium.
Stent 510 made of any of the above SMAs may have two distinct geometries that are temperature dependent. The metal may be configured in a first geometry 510a, as shown in FIGS. 24B,24C, at low temperatures, but will transition to a second geometry 510b at higher temperatures, as shown in
The transition from the compressed first geometry 510a, a low temperature state, to an expanded second geometry 510b, a higher temperature state, may occur after heating the SMA by exposing the SMA stent 510 to radiation emitting from the scanning module 302. Since stents are heat sensitive, a therapeutic beam or other radiation that may supply a safe amount of heat may be used to transition the stent 510 from the compressed first geometry 510a to the expanded second geometry 510b. In one embodiment the laser light may be emitted from the scanning module 302 of the scanning beam assembly 1. In one embodiment as shown in
In another embodiment, like those shown in
In another embodiment the SMA stent 510 may be wrapped in a mesh as taught in U.S. Pat. No. 5,545,211. The mesh may contain or be made of a radiation-responsive agent, a medical healing aide, or other treatment drug. The radiation-responsive agent may be radiation curable. The radiation curable radiation-responsive agent may be cured by exposure to the radiation emitted from the scanning module 502 as described above.
In another embodiment, the present invention includes a method for repairing or modifying an area of a patient's anatomy includes the steps of directing at least a portion of a scanning beam assembly to an area of a patient's anatomy, displaying an image of the anatomy, identifying a portion of the anatomy where radiation can be used to open a channel within a portion of the anatomy, and emitting the radiation to make the channel. The area of the anatomy may be the heart. Channels may be made into the heart (e.g., the wall of the heart) to isolate electrical signals. These channels may be used to treat arrhythmia or cause revascularization. In one embodiment, the scanning beam assembly may be simply used to visualize or image the making of the channel. In another embodiment, the scanning beam assembly may emit radiation that is capable of removing or making a channel opening through an occlusion within a lumen or organ of the body.
In one embodiment, the scanning beam assembly may be used to visualize or image a patient's anatomy. The scanning beam assembly may be used to image any medical procedure. In one embodiment, the assembly may be used to image the placement of stents or grafts within the body.
While the present invention has been illustrated by description of several embodiments, it is not the intention of the applicant to restrict or limit the spirit and scope of the appended claims to such detail. Numerous other variations, changes, and substitutions will occur to those skilled in the art without departing from the scope of the invention. For instance, the assembly and method of the present invention has been illustrated in relation to repairing a site with a body using a scanning beam assembly, but it will be understood the present invention has applicability to other uses of a scanning beam assembly. Moreover, the structure of each element associated with the present invention can be alternatively described as a means for providing the function performed by the element. It will be understood that the foregoing description is provided by way of example, and that other modifications may occur to those skilled in the art without departing from the scope and spirit of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
3758199 | Thaxter | Sep 1973 | A |
3959582 | Law et al. | May 1976 | A |
4082635 | Fritz et al. | Apr 1978 | A |
4141362 | Wurster | Feb 1979 | A |
4313431 | Frank | Feb 1982 | A |
4379039 | Fujimoto et al. | Apr 1983 | A |
4403273 | Nishioka | Sep 1983 | A |
4409477 | Carl | Oct 1983 | A |
4421382 | Doi et al. | Dec 1983 | A |
4524761 | Hattori et al. | Jun 1985 | A |
4527552 | Hattori | Jul 1985 | A |
4573465 | Sugiyama et al. | Mar 1986 | A |
4576999 | Eckberg | Mar 1986 | A |
4597380 | Raif et al. | Jul 1986 | A |
4643967 | Bryant | Feb 1987 | A |
4676231 | Hisazumi et al. | Jun 1987 | A |
4760840 | Fournier, Jr. et al. | Aug 1988 | A |
4803550 | Yabe et al. | Feb 1989 | A |
4872458 | Kanehira et al. | Oct 1989 | A |
4902083 | Wells | Feb 1990 | A |
4902115 | Takahashi | Feb 1990 | A |
4934773 | Becker | Jun 1990 | A |
4938205 | Nudelman | Jul 1990 | A |
5003300 | Wells | Mar 1991 | A |
5023905 | Wells et al. | Jun 1991 | A |
5048077 | Wells et al. | Sep 1991 | A |
5074860 | Gregory et al. | Dec 1991 | A |
5078150 | Hara et al. | Jan 1992 | A |
5163936 | Black et al. | Nov 1992 | A |
5163945 | Ortiz et al. | Nov 1992 | A |
5172685 | Nudelman | Dec 1992 | A |
5192288 | Thompson et al. | Mar 1993 | A |
5200819 | Nudelman et al. | Apr 1993 | A |
5200838 | Nudelman et al. | Apr 1993 | A |
5207670 | Sinofsky | May 1993 | A |
5218195 | Hakamata | Jun 1993 | A |
5251025 | Cooper et al. | Oct 1993 | A |
5251613 | Adair | Oct 1993 | A |
5269289 | Takehana et al. | Dec 1993 | A |
5318024 | Kittrell et al. | Jun 1994 | A |
5334991 | Wells et al. | Aug 1994 | A |
5368015 | Wilk | Nov 1994 | A |
5370643 | Krivoshlykov et al. | Dec 1994 | A |
5387197 | Smith et al. | Feb 1995 | A |
5393647 | Neukermans et al. | Feb 1995 | A |
5436655 | Hiyama et al. | Jul 1995 | A |
5464013 | Lemelson | Nov 1995 | A |
5467104 | Furness, III et al. | Nov 1995 | A |
5488862 | Neukermans et al. | Feb 1996 | A |
5531740 | Black | Jul 1996 | A |
5545211 | An et al. | Aug 1996 | A |
5552452 | Khadem et al. | Sep 1996 | A |
5557444 | Melville et al. | Sep 1996 | A |
5590660 | MacAulay et al. | Jan 1997 | A |
5596339 | Furness, III et al. | Jan 1997 | A |
5608451 | Konno et al. | Mar 1997 | A |
5629790 | Neukermans et al. | May 1997 | A |
5648618 | Neukermans et al. | Jul 1997 | A |
5649952 | Lam | Jul 1997 | A |
5657165 | Karpman et al. | Aug 1997 | A |
5658710 | Neukermans | Aug 1997 | A |
5659327 | Furness, III et al. | Aug 1997 | A |
5694237 | Melville | Dec 1997 | A |
5701132 | Kollin et al. | Dec 1997 | A |
5713891 | Poppas | Feb 1998 | A |
5728121 | Bimbo et al. | Mar 1998 | A |
5735792 | Vanden Hoek et al. | Apr 1998 | A |
5742419 | Dickensheets et al. | Apr 1998 | A |
5742421 | Wells et al. | Apr 1998 | A |
5751465 | Melville et al. | May 1998 | A |
5768461 | Svetkoff et al. | Jun 1998 | A |
5797944 | Nobles et al. | Aug 1998 | A |
5817061 | Goodwin et al. | Oct 1998 | A |
5823943 | Tomioka et al. | Oct 1998 | A |
5827176 | Tanaka et al. | Oct 1998 | A |
5827190 | Palcic et al. | Oct 1998 | A |
5841553 | Neukermans | Nov 1998 | A |
5861549 | Neukermans et al. | Jan 1999 | A |
5867297 | Kiang et al. | Feb 1999 | A |
5895866 | Neukermans et al. | Apr 1999 | A |
5903397 | Melville et al. | May 1999 | A |
5907425 | Dickensheets et al. | May 1999 | A |
5913591 | Melville | Jun 1999 | A |
5947930 | Schwemberger et al. | Sep 1999 | A |
5951543 | Brauer | Sep 1999 | A |
5969465 | Neukermans et al. | Oct 1999 | A |
5969871 | Tidwell et al. | Oct 1999 | A |
5982528 | Melville | Nov 1999 | A |
5982555 | Melville et al. | Nov 1999 | A |
5989244 | Gregory et al. | Nov 1999 | A |
5993037 | Tomioka et al. | Nov 1999 | A |
5995264 | Melville | Nov 1999 | A |
6007208 | Dickensheets et al. | Dec 1999 | A |
6008781 | Furness, III et al. | Dec 1999 | A |
6013025 | Bonne et al. | Jan 2000 | A |
6016440 | Simon et al. | Jan 2000 | A |
6017356 | Frederick et al. | Jan 2000 | A |
6017603 | Tokuda et al. | Jan 2000 | A |
6024744 | Kese et al. | Feb 2000 | A |
6043799 | Tidwell | Mar 2000 | A |
6044705 | Neukermans et al. | Apr 2000 | A |
6046720 | Melville et al. | Apr 2000 | A |
6049407 | Melville | Apr 2000 | A |
6056721 | Shulze | May 2000 | A |
6057952 | Kubo et al. | May 2000 | A |
6059720 | Furusawa et al. | May 2000 | A |
6061163 | Melville | May 2000 | A |
6064779 | Neukermans et al. | May 2000 | A |
6069725 | Melville | May 2000 | A |
6086528 | Adair | Jul 2000 | A |
6086531 | Tomioka et al. | Jul 2000 | A |
6088145 | Dickensheets et al. | Jul 2000 | A |
6097353 | Melville et al. | Aug 2000 | A |
6122394 | Neukermans et al. | Sep 2000 | A |
6139175 | Tomioka et al. | Oct 2000 | A |
6140979 | Gerhard et al. | Oct 2000 | A |
6151167 | Melville | Nov 2000 | A |
6154305 | Dickensheets et al. | Nov 2000 | A |
6154321 | Melville et al. | Nov 2000 | A |
6157352 | Kollin et al. | Dec 2000 | A |
6166841 | Melville | Dec 2000 | A |
6172789 | Kino et al. | Jan 2001 | B1 |
6178346 | Amundson et al. | Jan 2001 | B1 |
6179776 | Adams et al. | Jan 2001 | B1 |
6191761 | Melville et al. | Feb 2001 | B1 |
6192267 | Scherninski et al. | Feb 2001 | B1 |
6200595 | Motoyashiki et al. | Mar 2001 | B1 |
6204829 | Tidwell | Mar 2001 | B1 |
6204832 | Melville et al. | Mar 2001 | B1 |
6207392 | Weiss et al. | Mar 2001 | B1 |
6210401 | Lai | Apr 2001 | B1 |
6220711 | Melville | Apr 2001 | B1 |
6221068 | Fried et al. | Apr 2001 | B1 |
6229139 | Neukermans et al. | May 2001 | B1 |
6235017 | Jegorov et al. | May 2001 | B1 |
6243186 | Melville | Jun 2001 | B1 |
6245590 | Wine et al. | Jun 2001 | B1 |
6256131 | Wine et al. | Jul 2001 | B1 |
6257727 | Melville | Jul 2001 | B1 |
6272907 | Neukermans et al. | Aug 2001 | B1 |
6276798 | Gil et al. | Aug 2001 | B1 |
6281862 | Tidwell et al. | Aug 2001 | B1 |
6284185 | Tokuda et al. | Sep 2001 | B1 |
6285489 | Helsel et al. | Sep 2001 | B1 |
6285505 | Melville et al. | Sep 2001 | B1 |
6288816 | Melville et al. | Sep 2001 | B1 |
6292287 | Fujinoki | Sep 2001 | B1 |
6293911 | Imaizumi et al. | Sep 2001 | B1 |
6294239 | Tokuda et al. | Sep 2001 | B1 |
6294775 | Seibel et al. | Sep 2001 | B1 |
6317103 | Furness, III et al. | Nov 2001 | B1 |
6323037 | Lauto et al. | Nov 2001 | B1 |
6324007 | Melville | Nov 2001 | B1 |
6327493 | Ozawa et al. | Dec 2001 | B1 |
6331909 | Dunfield | Dec 2001 | B1 |
6333110 | Barbera-Guillem | Dec 2001 | B1 |
6338641 | Nicholls | Jan 2002 | B2 |
6352344 | Tidwell | Mar 2002 | B2 |
6353183 | Ott et al. | Mar 2002 | B1 |
6362912 | Lewis et al. | Mar 2002 | B1 |
6364829 | Fulghum | Apr 2002 | B1 |
6369928 | Mandella et al. | Apr 2002 | B1 |
6369953 | Melville et al. | Apr 2002 | B2 |
6369954 | Berge et al. | Apr 2002 | B1 |
6370406 | Wach et al. | Apr 2002 | B1 |
6370422 | Richards-Kortum et al. | Apr 2002 | B1 |
6373995 | Moore | Apr 2002 | B1 |
6384406 | Wine et al. | May 2002 | B1 |
6388641 | Tidwell et al. | May 2002 | B2 |
6392220 | Slater et al. | May 2002 | B1 |
6396461 | Lewis et al. | May 2002 | B1 |
6414779 | Mandella et al. | Jul 2002 | B1 |
6417502 | Stoner et al. | Jul 2002 | B1 |
6423956 | Mandella et al. | Jul 2002 | B1 |
6425900 | Knodel et al. | Jul 2002 | B1 |
6426013 | Neukermans et al. | Jul 2002 | B1 |
6433907 | Lippert et al. | Aug 2002 | B1 |
6435637 | Lyman | Aug 2002 | B1 |
6441356 | Mandella et al. | Aug 2002 | B1 |
6445362 | Tegreene | Sep 2002 | B1 |
6447524 | Knodel et al. | Sep 2002 | B1 |
6462770 | Cline et al. | Oct 2002 | B1 |
6464363 | Nishioka et al. | Oct 2002 | B1 |
6467345 | Neukermans et al. | Oct 2002 | B1 |
6470124 | Le Gargasson et al. | Oct 2002 | B1 |
6477403 | Eguchi et al. | Nov 2002 | B1 |
6478809 | Brotz | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6492962 | Melville et al. | Dec 2002 | B2 |
6494578 | Plummer et al. | Dec 2002 | B1 |
6503196 | Kehr et al. | Jan 2003 | B1 |
6510338 | Irion et al. | Jan 2003 | B1 |
6512622 | Wine et al. | Jan 2003 | B2 |
6513939 | Fettig et al. | Feb 2003 | B1 |
6515278 | Wine et al. | Feb 2003 | B2 |
6515781 | Lewis et al. | Feb 2003 | B2 |
6520972 | Peters | Feb 2003 | B2 |
6522444 | Mandella et al. | Feb 2003 | B2 |
6525310 | Dunfield | Feb 2003 | B2 |
6527708 | Nakamura et al. | Mar 2003 | B1 |
6529770 | Grimblatov | Mar 2003 | B1 |
6530698 | Kuhara et al. | Mar 2003 | B1 |
6535183 | Melville et al. | Mar 2003 | B2 |
6535325 | Helsel et al. | Mar 2003 | B2 |
6537211 | Wang et al. | Mar 2003 | B1 |
6538625 | Tidwell et al. | Mar 2003 | B2 |
6545260 | Katashiro et al. | Apr 2003 | B1 |
6560028 | Melville et al. | May 2003 | B2 |
6563105 | Seibel et al. | May 2003 | B2 |
6563106 | Bowers et al. | May 2003 | B1 |
6572606 | Kliewer et al. | Jun 2003 | B2 |
6583117 | Owen et al. | Jun 2003 | B2 |
6583772 | Lewis et al. | Jun 2003 | B1 |
6585642 | Christopher | Jul 2003 | B2 |
6603552 | Cline et al. | Aug 2003 | B1 |
6608297 | Neukermans et al. | Aug 2003 | B2 |
6639570 | Furness, III et al. | Oct 2003 | B2 |
6639719 | Tegreene et al. | Oct 2003 | B2 |
6650877 | Tarbouriech et al. | Nov 2003 | B1 |
6653621 | Wine et al. | Nov 2003 | B2 |
6654158 | Helsel et al. | Nov 2003 | B2 |
6661393 | Tegreene et al. | Dec 2003 | B2 |
6674993 | Tarbouriech | Jan 2004 | B1 |
6685804 | Ikeda et al. | Feb 2004 | B1 |
6687034 | Wine et al. | Feb 2004 | B2 |
6689056 | Kilcoyne et al. | Feb 2004 | B1 |
6699170 | Crocker et al. | Mar 2004 | B1 |
6700552 | Kollin et al. | Mar 2004 | B2 |
6714331 | Lewis et al. | Mar 2004 | B2 |
6734835 | Tidwell et al. | May 2004 | B2 |
6736511 | Plummer et al. | May 2004 | B2 |
6741884 | Freeman et al. | May 2004 | B1 |
6749346 | Dickensheets et al. | Jun 2004 | B1 |
6755536 | Tegreene et al. | Jun 2004 | B2 |
6762867 | Lippert et al. | Jul 2004 | B2 |
6768588 | Urey | Jul 2004 | B2 |
6771001 | Mao et al. | Aug 2004 | B2 |
6782748 | Weber et al. | Aug 2004 | B2 |
6786382 | Hoffman | Sep 2004 | B1 |
6795221 | Urey | Sep 2004 | B1 |
6802809 | Okada | Oct 2004 | B2 |
6803561 | Dunfield | Oct 2004 | B2 |
6821245 | Cline et al. | Nov 2004 | B2 |
6845190 | Smithwick et al. | Jan 2005 | B1 |
6855139 | Ahle et al. | Feb 2005 | B2 |
6856436 | Brukilacchio et al. | Feb 2005 | B2 |
6856712 | Fauver et al. | Feb 2005 | B2 |
6879428 | Massieu | Apr 2005 | B2 |
6888552 | Debevec et al. | May 2005 | B2 |
6894823 | Taylor et al. | May 2005 | B2 |
6899675 | Cline et al. | May 2005 | B2 |
6902527 | Doguchi et al. | Jun 2005 | B1 |
6905057 | Swayze et al. | Jun 2005 | B2 |
6939364 | Soltz et al. | Sep 2005 | B1 |
6957898 | Yu | Oct 2005 | B2 |
6967757 | Allen et al. | Nov 2005 | B1 |
6974472 | Hong et al. | Dec 2005 | B2 |
6975898 | Seibel et al. | Dec 2005 | B2 |
6976994 | Ballou et al. | Dec 2005 | B2 |
6978921 | Shelton, IV et al. | Dec 2005 | B2 |
6985271 | Yazdi et al. | Jan 2006 | B2 |
6991602 | Nakazawa et al. | Jan 2006 | B2 |
7005195 | Cheng et al. | Feb 2006 | B2 |
7009634 | Iddan et al. | Mar 2006 | B2 |
7013730 | Malametz | Mar 2006 | B2 |
7015956 | Luo et al. | Mar 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7023402 | Lewis et al. | Apr 2006 | B2 |
7025777 | Moore | Apr 2006 | B2 |
7033348 | Alfano et al. | Apr 2006 | B2 |
7035777 | Araki et al. | Apr 2006 | B2 |
7061450 | Bright et al. | Jun 2006 | B2 |
7065301 | Shastri et al. | Jun 2006 | B2 |
7066879 | Fowler et al. | Jun 2006 | B2 |
7071594 | Yan et al. | Jul 2006 | B1 |
7071931 | Tegreene et al. | Jul 2006 | B2 |
7078378 | Owen et al. | Jul 2006 | B1 |
7108656 | Fujikawa et al. | Sep 2006 | B2 |
7112302 | Yoshimi et al. | Sep 2006 | B2 |
7126903 | Feenstra et al. | Oct 2006 | B2 |
7189961 | Johnston et al. | Mar 2007 | B2 |
7190329 | Lewis et al. | Mar 2007 | B2 |
7232071 | Lewis et al. | Jun 2007 | B2 |
7271383 | Chee | Sep 2007 | B2 |
7391013 | Johnston et al. | Jun 2008 | B2 |
20010055462 | Seibel | Dec 2001 | A1 |
20020015724 | Yang et al. | Feb 2002 | A1 |
20020024495 | Lippert et al. | Feb 2002 | A1 |
20020050956 | Gerhard et al. | May 2002 | A1 |
20020075284 | Rabb, III | Jun 2002 | A1 |
20020088925 | Nestorovic et al. | Jul 2002 | A1 |
20020115922 | Waner et al. | Aug 2002 | A1 |
20020141026 | Wiklof et al. | Oct 2002 | A1 |
20020158814 | Bright et al. | Oct 2002 | A1 |
20020163484 | Furness, III et al. | Nov 2002 | A1 |
20020167462 | Lewis et al. | Nov 2002 | A1 |
20020171776 | Tegreene et al. | Nov 2002 | A1 |
20020171937 | Tegreene et al. | Nov 2002 | A1 |
20030016187 | Melville et al. | Jan 2003 | A1 |
20030030753 | Kondo et al. | Feb 2003 | A1 |
20030032143 | Neff et al. | Feb 2003 | A1 |
20030034709 | Jerman | Feb 2003 | A1 |
20030058190 | Lewis et al. | Mar 2003 | A1 |
20030086172 | Urey | May 2003 | A1 |
20030092995 | Thompson | May 2003 | A1 |
20030130562 | Barbato et al. | Jul 2003 | A1 |
20030142934 | Pan et al. | Jul 2003 | A1 |
20030159447 | Sergio et al. | Aug 2003 | A1 |
20030214460 | Kovacs | Nov 2003 | A1 |
20030216729 | Marchitto et al. | Nov 2003 | A1 |
20040004585 | Brown et al. | Jan 2004 | A1 |
20040057103 | Bernstein | Mar 2004 | A1 |
20040075624 | Tegreene et al. | Apr 2004 | A1 |
20040076390 | Dong Yang et al. | Apr 2004 | A1 |
20040085261 | Lewis et al. | May 2004 | A1 |
20040085617 | Helsel et al. | May 2004 | A1 |
20040087844 | Yen | May 2004 | A1 |
20040101822 | Wiesner et al. | May 2004 | A1 |
20040113059 | Kawano et al. | Jun 2004 | A1 |
20040118821 | Han et al. | Jun 2004 | A1 |
20040119004 | Wine et al. | Jun 2004 | A1 |
20040122328 | Wang et al. | Jun 2004 | A1 |
20040133786 | Tarbouriech | Jul 2004 | A1 |
20040151466 | Crossman-Bosworth et al. | Aug 2004 | A1 |
20040155186 | Nestorovic et al. | Aug 2004 | A1 |
20040155834 | Wit et al. | Aug 2004 | A1 |
20040179254 | Lewis et al. | Sep 2004 | A1 |
20040196518 | Wine et al. | Oct 2004 | A1 |
20040223202 | Lippert et al. | Nov 2004 | A1 |
20040225222 | Zeng et al. | Nov 2004 | A1 |
20040236371 | McNally-Heintzelman et al. | Nov 2004 | A1 |
20040240866 | Ramsbottom | Dec 2004 | A1 |
20040252377 | Urey | Dec 2004 | A1 |
20040254474 | Seibel et al. | Dec 2004 | A1 |
20050010787 | Tarbouriech | Jan 2005 | A1 |
20050014995 | Amundson et al. | Jan 2005 | A1 |
20050020877 | Ishihara et al. | Jan 2005 | A1 |
20050020926 | Wiklof et al. | Jan 2005 | A1 |
20050023356 | Wiklof et al. | Feb 2005 | A1 |
20050030305 | Brown et al. | Feb 2005 | A1 |
20050038322 | Banik | Feb 2005 | A1 |
20050116038 | Lewis et al. | Jun 2005 | A1 |
20050162762 | Novak | Jul 2005 | A1 |
20050187441 | Kawasaki et al. | Aug 2005 | A1 |
20050203343 | Kang et al. | Sep 2005 | A1 |
20050240147 | Makower et al. | Oct 2005 | A1 |
20060010985 | Schneider | Jan 2006 | A1 |
20060084867 | Tremblay et al. | Apr 2006 | A1 |
20060122619 | Kablik et al. | Jun 2006 | A1 |
20060164330 | Bright et al. | Jul 2006 | A1 |
20060183246 | Wiesner et al. | Aug 2006 | A1 |
20060195014 | Seibel et al. | Aug 2006 | A1 |
20060212070 | Redmond et al. | Sep 2006 | A1 |
20060238774 | Lindner et al. | Oct 2006 | A1 |
20060245971 | Burns et al. | Nov 2006 | A1 |
20060284790 | Tegreene et al. | Dec 2006 | A1 |
20070005140 | Kim et al. | Jan 2007 | A1 |
20070038119 | Chen et al. | Feb 2007 | A1 |
20070046778 | Ishihara et al. | Mar 2007 | A1 |
20070135770 | Hunt et al. | Jun 2007 | A1 |
20070156021 | Morse et al. | Jul 2007 | A1 |
20070161876 | Bambot et al. | Jul 2007 | A1 |
20070162093 | Porter et al. | Jul 2007 | A1 |
20070167681 | Gill et al. | Jul 2007 | A1 |
20070173707 | Mitra | Jul 2007 | A1 |
20070179366 | Pewzner et al. | Aug 2007 | A1 |
20070197874 | Ishihara | Aug 2007 | A1 |
20070197875 | Osaka | Aug 2007 | A1 |
20070203413 | Frangioni | Aug 2007 | A1 |
20070213588 | Morishita et al. | Sep 2007 | A1 |
20070213618 | Li et al. | Sep 2007 | A1 |
20070225695 | Mayer et al. | Sep 2007 | A1 |
20070238930 | Wiklof et al. | Oct 2007 | A1 |
20070244365 | Wiklof | Oct 2007 | A1 |
20070260121 | Bakos et al. | Nov 2007 | A1 |
20070260273 | Cropper et al. | Nov 2007 | A1 |
20080033287 | Schwarze et al. | Feb 2008 | A1 |
20080058629 | Seibel et al. | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
3837248 | May 1990 | DE |
1139141 | Oct 2001 | EP |
1716802 | Nov 2006 | EP |
1747751 | Jan 2007 | EP |
1797813 | Jun 2007 | EP |
2007-244590 | Sep 2007 | JP |
2007-244680 | Sep 2007 | JP |
WO 9813720 | Apr 1998 | WO |
WO 9918456 | Apr 1999 | WO |
9958930 | Nov 1999 | WO |
0013210 | Mar 2000 | WO |
0110322 | Feb 2001 | WO |
0160274 | Aug 2001 | WO |
02062239 | Aug 2002 | WO |
WO 03069380 | Aug 2003 | WO |
03088643 | Oct 2003 | WO |
03098918 | Nov 2003 | WO |
03101287 | Nov 2003 | WO |
2006020605 | Feb 2006 | WO |
WO 2006049787 | May 2006 | WO |
WO 2006055733 | May 2006 | WO |
2007041542 | Apr 2007 | WO |
2007070831 | Jun 2007 | WO |
WO 2007067163 | Jun 2007 | WO |
WO 2007084915 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20080312490 A1 | Dec 2008 | US |